.png "Maximilian Konig, MD photo")
The Johns Hopkins University School of Medicine
Baltimore, MD, United States
Maximilian F. Konig is an Assistant Professor of Medicine in the Division of Rheumatology and Ludwig Center for Cancer Genetics and Therapeutics, and the Director of the Cellular Therapy Program (Autoimmunity) at the Johns Hopkins University School of Medicine. Dr. Konig received his medical degree from Charité – Universitätsmedizin Berlin and Humboldt-Universität zu Berlin in Germany. He completed residency training in Internal Medicine in the Stanbury Physician-Scientist Pathway at Massachusetts General Hospital, Harvard Medical School, and fellowship training in Clinical and Molecular Rheumatology at Johns Hopkins Hospital. His research program is focused on developing and advancing precision T cell therapies for the treatment of autoimmune rheumatic disease and cancer.
Saturday, October 25, 2025
10:45 AM – 11:15 AM Central Time
Disclosure(s): Allogene: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Argenx: Advisor or Review Panel Member (Terminated, December 31, 2024), Consultant (Terminated, December 31, 2024); Atara Biotherapeutics: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Revel Pharmaceuticals: Consultant (Ongoing); Sana Biotechnology: Advisor or Review Panel Member (Terminated), Consultant (Terminated); Sanofi: Consultant (Terminated); TBD Pharmaceuticals, Inc.: Consultant (Ongoing), Intellectual Property/Patents (Ongoing), Officer or Board Member (Ongoing), Ownership Interest (Ongoing), Royalties (Ongoing)
